Schobel Alexander Mark - Insider Non-Derivative Transactions at Aquestive Therapeutics, Inc. (AQST) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 15, 2024, Schobel Alexander Mark's relationship to Aquestive Therapeutics, Inc. (AQST) is Officer (Chief Innovation/Tech Officer), and currently has 984,476 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AQST insiders.

Data Source: SEC.
Schobel Alexander Mark - Insider Non-Derivative Transactions of AQST Common Stock
Schobel Alexander Mark - Insider Non-Derivative Transactions at AQST
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 16, 2024 Sell -- (Common Stock) 50000 6 984476
Mar 10, 2024 F -- (Common Stock) 5895 4.88 1034476
Mar 9, 2024 Sell -- (Common Stock) 25000 5.19 1040371
Mar 8, 2024 Acquisition -- (Common Stock) 82500 0 1065371
Mar 10, 2023 Acquisition -- (Common Stock) 100000 0 982871